Evidence map›Paper›PMID 32054932›Full record

ArticleScientific reports2020

Assessing the progression of systemic sclerosis by monitoring the tissue optic axis using PS-OCT.

David C Adams, Margit V Szabari, David Lagares, Andrew F McCrossan, Lida P Hariri, Andrew M Tager, Melissa J Suter

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Biomedical optics express · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Novel Imaging Strategies in Systemic Sclerosis.Current rheumatology reports · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

David C Adams *Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, 40 Blossom Street, Boston, Massachusetts, 02114, USA.
Margit V Szabari *Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, 40 Blossom Street, Boston, Massachusetts, 02114, USA.
David LagaresDivision of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, 40 Blossom Street, Boston, Massachusetts, 02114, USA.ORCID http://orcid.org/0000-0002-7317-8796
Andrew F McCrossanDivision of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, 40 Blossom Street, Boston, Massachusetts, 02114, USA.
Lida P HaririDivision of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, 40 Blossom Street, Boston, Massachusetts, 02114, USA.
Andrew M TagerDivision of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, 40 Blossom Street, Boston, Massachusetts, 02114, USA.
Melissa J SuterDivision of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, 40 Blossom Street, Boston, Massachusetts, 02114, USA. msuter@mgh.harvard.edu.
Harvard University · USMassachusetts General Hospital · US

Funding

Phenotyping Asthma for Bronchial Thermoplasty: Airway Smooth Muscle Structure and FunctionR01HL133664 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI SUTER, MELISSA J · 2017 to 2021
$3.7M
Increasing the diagnostic yield of low-risk bronchial biopsy in the evaluation ofR01CA167827 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BOUMA, BRETT E, SUTER, MELISSA J · 2013 to 2017
$2.7M
NHLBI NIH HHS R01 HL133664U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA167827
6 · The paper itself

Abstract

The clinical assessment of fibrosis is critical to the diagnosis and management of patients with systemic sclerosis. Current clinical standards for patient assessment is to use skin fibrosis as an indicator of organ involvement, though this approach is highly subjective and relies on manual palpation. The development of a new method for accurately quantifying collagen content may therefore significantly improve the accuracy of the traditional skin score in patients with systemic sclerosis and may additionally aid in the monitoring of anti-fibrotic therapies in clinical practice. Polarization-sensitive optical coherence tomography (PS-OCT) is a high-speed volumetric imaging modality that can be used to assess birefringent tissues including collagen. In this work we demonstrate a novel computational approach using PS-OCT for the assessment of fibrosis. This approach, based on the measured distribution of optic axis values associated with a given volume of collagen orientation, characterizes fibrotic changes independently from the depth of the region of interest in the tissue. This approach has the potential to accurately quantify collagen content and orientation faster and more robustly compared to traditional PS-OCT metrics. We investigate the viability of this approach for assessing the development of fibrosis in a bleomycin induced skin fibrosis mouse model.

Indexed as

AnimalsBleomycinCollagenDisease ProgressionEyeFibrosisHumansImage Processing, Computer-AssistedMiceRefraction, OcularScleroderma, SystemicTomography, Optical CoherenceBleomycinCollagen

Identifiers

PMID32054932
PMCPMC7018967
OpenAlexW3006280848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.